Arkolith/Insider Trading/ZVSA/Form 4

O'Connor Daniel J.

Director, 10% OwnerZyVersa Therapeutics, Inc. (ZVSA) · full profile →Form 4 · filed Dec 14, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 12, 2022Other(J)1.4M—$01.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 12, 2022Other(J)2K——2K
Dec 12, 2022Other(J)2K——2K
Dec 12, 2022Other(J)177K—$0177K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-035477) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML